The future Spanish vaccine against COVID-19 in which the Hipra laboratories, based in Amer (Girona) are working, presents good results against the omicron variant, according to the Minister of Science and Innovation, Diana Morant, assured this Tuesday.
Morant has visited the facilities of this company and recalled that he works with the method of recombining proteins, which is designed for alpha and beta strains, but can be adapted to those that “may arise”.
“The results and the resistance presented by the vaccine that is being tested today against the new variant, against the omicron, have just told me that it is good,” said the minister, who hopes that it will be marketed in the second quarter of this year.
“I would like it to be the year of Hipra”, said the minister, who stressed that the company is awaiting authorization from the Spanish Agency for Medicines and Health Products (AEMPS) to move to phase III of the clinical trial this January.
Morant has also advanced that, “if everything goes well”, the vaccine could be ready for the second quarter of 2022.
Source: ElDiario.es – ElDiario.es by www.eldiario.es.
*The article has been translated based on the content of ElDiario.es – ElDiario.es by www.eldiario.es. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!